Gene By Gene Competitors and Similar CompaniesClear all

Gene By Gene's competitors and similar companies include Personalis, DNA Direct, 23andMe and Affymetrix.

	Gene By Gene Gene by Gene is a company that offers a range of DNA testing services for purposes ranging from personal to legal.	Personalis Personalis is a biotechnology company that specializes in cancer genomics.	DNA Direct DNA Direct Solutions is a company that collects biological specimens and performs DNA testing.	23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.	Affymetrix Affymetrix is a company engaged in microarray technology and genomics analysis.
Founding Date	Founding Date 2000	Founding Date 2011	Founding Date N/A	Founding Date 2006	Founding Date 1994
Type	Type Subsidiary	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research genetics	Tags Technology biotech genetics platform	Tags Healthcare biotech ecommerce genetics	Tags Healthcare biotech genetics healthtech holding company	Tags Healthcare biotech clinical research genetics
Locations	Locations Houston, US HQ	Locations Fremont, US HQ West Wickham, GB	Locations Las Cruces, US HQ	Locations Sunnyvale, US HQ South San Francisco, US	Locations Santa Clara, US HQ
Employees	Employees 1021% decrease	Employees 22344% decrease	Employees N/A	Employees 56027% decrease	Employees 429
Valuation ($)	Valuation ($) N/A	Valuation ($) 340.9 m	Valuation ($) N/A	Valuation ($) 169.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $69.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $189.9m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $53.9m (FY, 2025)	Cost of goods N/A	Cost of goods $89.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $15.8m (FY, 2025)	Gross profit N/A	Gross profit $100m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($81.3m) (FY, 2025)	Net income N/A	Net income ($280.9m) (FY, 2025)	Net income N/A
Operating ⚠
Patents Issued	Patents Issued N/A	Patents Issued 16 (FY, 2021)	Patents Issued N/A	Patents Issued 93 (FY, 2022)	Patents Issued N/A
Trademarks (US)	Trademarks (US) 7 (Feb, 2022)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 48 (Nov, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 75m	Total funding raised N/A	Total funding raised $ 912.5m	Total funding raised N/A